Page last updated: 2024-08-26

sr141716 and Cognition Disorders

sr141716 has been researched along with Cognition Disorders in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (80.00)	29.6817
2010's	1 (20.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boggs, DL; Buchanan, RW; Conley, RR; Gold, JM; Gorelick, DA; Huestis, MA; Kelly, DL; Linthicum, J; Liu, F; McMahon, RP; Waltz, J	1
Abel, N; Avraham, Y; Berry, EM; Mechoulam, R; Menachem, AB; Okun, A; Zlotarav, O	1
Khiabani, HZ; Mørland, J	1
Hefetz, A; Keren, O; Sarne, Y; Senn, R	1

Reviews

2 review(s) available for sr141716 and Cognition Disorders

Article	Year
[Cannabis and cannabinoids as drugs]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2007, Mar-01, Volume: 127, Issue:5 Topics: Cannabinoid Receptor Antagonists; Cannabinoids; Cannabis; Cognition Disorders; Dronabinol; Humans; Piperidines; Psychoses, Substance-Induced; Psychotropic Drugs; Pyrazoles; Receptors, Cannabinoid; Rimonabant; Risk Factors	2007
Rimonabant. SR 141716, SR 141716a. Drugs in R&D, 2002, Volume: 3, Issue:1 Topics: Alzheimer Disease; Clinical Trials as Topic; Cognition Disorders; Humans; Obesity; Piperidines; Pyrazoles; Rimonabant	2002

Trials

1 trial(s) available for sr141716 and Cognition Disorders

Article	Year
Rimonabant for neurocognition in schizophrenia: a 16-week double blind randomized placebo controlled trial. Schizophrenia research, 2012, Volume: 134, Issue:2-3 Topics: Adolescent; Adult; Analysis of Variance; Cannabinoid Receptor Antagonists; Cognition Disorders; Depression; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neuropsychological Tests; Piperidines; Psychiatric Status Rating Scales; Pyrazoles; Rimonabant; Schizophrenia; Treatment Outcome; Young Adult	2012

Article

Year

Rimonabant for neurocognition in schizophrenia: a 16-week double blind randomized placebo controlled trial.

Schizophrenia research, 2012, Volume: 134, Issue:2-3

Topics: Adolescent; Adult; Analysis of Variance; Cannabinoid Receptor Antagonists; Cognition Disorders; Depression; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neuropsychological Tests; Piperidines; Psychiatric Status Rating Scales; Pyrazoles; Rimonabant; Schizophrenia; Treatment Outcome; Young Adult

2012

Other Studies

2 other study(ies) available for sr141716 and Cognition Disorders

Article	Year
Effects of the endocannabinoid noladin ether on body weight, food consumption, locomotor activity, and cognitive index in mice. Brain research bulletin, 2005, Mar-15, Volume: 65, Issue:2 Topics: Animals; Body Weight; Cannabinoid Receptor Modulators; Cognition; Cognition Disorders; Dose-Response Relationship, Drug; Eating; Endocannabinoids; Feeding and Eating Disorders; Female; Food Deprivation; Glycerides; Mice; Mice, Inbred C57BL; Motor Activity; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Species Specificity; Weight Gain	2005
Long-term cognitive deficits induced by a single, extremely low dose of tetrahydrocannabinol (THC): behavioral, pharmacological and biochemical studies in mice. Pharmacology, biochemistry, and behavior, 2008, Volume: 88, Issue:3 Topics: Animals; Behavior, Animal; Blotting, Western; Brain Chemistry; Cognition Disorders; Dronabinol; Enzyme Induction; Extracellular Signal-Regulated MAP Kinases; Hallucinogens; Male; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Piperidines; Psychomotor Performance; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant	2008

Article

Year

Effects of the endocannabinoid noladin ether on body weight, food consumption, locomotor activity, and cognitive index in mice.

Brain research bulletin, 2005, Mar-15, Volume: 65, Issue:2

Topics: Animals; Body Weight; Cannabinoid Receptor Modulators; Cognition; Cognition Disorders; Dose-Response Relationship, Drug; Eating; Endocannabinoids; Feeding and Eating Disorders; Female; Food Deprivation; Glycerides; Mice; Mice, Inbred C57BL; Motor Activity; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Species Specificity; Weight Gain

2005

Long-term cognitive deficits induced by a single, extremely low dose of tetrahydrocannabinol (THC): behavioral, pharmacological and biochemical studies in mice.

Pharmacology, biochemistry, and behavior, 2008, Volume: 88, Issue:3

Topics: Animals; Behavior, Animal; Blotting, Western; Brain Chemistry; Cognition Disorders; Dronabinol; Enzyme Induction; Extracellular Signal-Regulated MAP Kinases; Hallucinogens; Male; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Piperidines; Psychomotor Performance; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant

2008